Botulinum toxin type A in the healing of a chronic buttock ulcer in a patient with spastic paraplegia after spinal cord injury

Journal of Rehabilitation Medicine

Volumn 41, Issue 13, 2009, Pages 1100-1102

  Intiso, Domenico ^a   Basciani, Mario ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

Botulinum toxin; Spasm; Spinal cord injury; Ulcer

Indexed keywords

BACLOFEN; BOTULINUM TOXIN A; DANTROLENE; MUSCLE RELAXANT AGENT;

ADULT; ARTICLE; CASE REPORT; DECUBITUS; GLUTEUS MAXIMUS MUSCLE; HUMAN; MALE; MUSCLE SPASM; RECURRENT DISEASE; SCORING SYSTEM; SPASTIC PARAPLEGIA; SPASTICITY; SPINAL CORD INJURY; ULCER HEALING; BUTTOCK; CHRONIC DISEASE; DRUG EFFECT; PARAPLEGIA; WOUND HEALING;

ADULT; BOTULINUM TOXIN TYPE A; BUTTOCKS; CHRONIC DISEASE; HUMANS; MALE; MUSCLE SPASTICITY; NEUROMUSCULAR AGENTS; PARAPLEGIA; PRESSURE ULCER; RECURRENCE; SPINAL CORD INJURIES; WOUND HEALING;

EID: 70449732519     PISSN: 16501977     EISSN: None     Source Type: Journal    
DOI: 10.2340/16501977-0460     Document Type: Article

References (12)

1. Papapetropoulos S, Singer C. Botulinum toxin in movement disorders. Seminar Neurol 2007; 27: 183-194. (Pubitemid 46564479)
2. Vittal H, Pasricha PF. Botulinum toxin for gastrointestinal disorders: therapy and mechanisms. Neurotox Res 2006; 9: 149-159.
3. Oeconomou A, Madersbacher H, Kiss G, Berger TJ, Melekos M, Rehder P. Is botulinum neurotoxin type A (BoNT-A) a novel therapy for lower urinary tract symptoms due to benign prostatic enlargement? A review of the literature. Eur Neurol 2008; 54: 765-777.
4. Gassner HG, Brisset AE, Otley CC, Boahene DK, Boqqust AJ, Weaver AL, et al. Botulinum toxin to improve facial wound healing: a prospective, blinded, placebo-controlled study. Mayo Clin Proc 2006; 81: 1023-1028.
5. Wissel J, Ward AB, Erztgaard P, Bensmail D, Hecht MJ, Lejeune TM, et al. European consensus table on the use of botulinum toxin type A in adult spasticity. J Rehabil Med 2009; 41: 13-25.
6. Hitzig SL, Tonack M, Campbell KA, McGillivray CF, Boschen KA, Richards K, et al. Secondary health complications in aging Canadian spinal cord injury sample. Am J Phys Med Rehabil 2008; 87: 545-555.
7. Haisma JA, van der Woude LH, Stam HJ, Bergen MP, Sluis TA, Post MW, et al. Complications following spinal cord injury: occurrence and risk factors in a longitudinal study during and after inpatient rehabilitation. J Rehabil Med 2007; 39: 393-398.
8. Dorsett P, Geraghty T. Health-related outcomes of people with spinal cord injury - a 10 year longitudinal study. Spinal Cord 2008; 46: 386-391. (Pubitemid 351630963)
9. Platz T, Eickhof C, Nuyens G, Vuadens, P. Clinical scales for the assessment of spasticity, associated phenomena, and function: a systematic review of the literature. Disabil Rehabil 2005; 27: 7-18. (Pubitemid 40124835)
10. European Pressure Advisory Panel. [Cited 2009 Apr 3] Available from: http://www.epuap.org/grading.html.
11. Fruehauf H, Fried M, Wegmueller B, Bauerfeind P, Thumshirn M. Efficacy and safety of botulinum toxin A injection compared with topical nitroglycerin ointment for the treatment of chronic anal fissure: a prospective randomized study. Am J Gastroenterol 2006; 101: 2107-2112. (Pubitemid 44337637)
12. lntiso D, Basciani M, Di Rienzo F, Tolfa M, Grimaldi G, Fiore P. Botulinum toxin type A in the healing of ulcer following oromandibular dyskinesia in a patient in a vegetative state. J Rehabil Med 2008; 40: 315-316.